NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
ID: 348507Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/348507

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-198.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the NIAID New Innovator Awards (DP2 Clinical Trial Not Allowed) to support early-stage, creative biomedical researchers proposing innovative research concepts in infectious diseases, immunology, and allergies. This grant opportunity is aimed at postdoctoral researchers and newly independent Early Stage Investigators, allowing them to request up to $300,000 annually for a maximum of five years to foster groundbreaking research that may not yet have sufficient preliminary data. Applications must be submitted through the Grants.gov platform by 5 PM local time on October 10, 2025, and will be evaluated based on significance, innovation, investigator qualifications, and overall impact. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-198-Full-Announcement.html
    PAR-23-198.html
    The NIAID New Innovator Awards, part of the NIH Director's New Innovator Awards program, targets early-stage, creative biomedical researchers with exceptional insights for impactful research in infectious diseases, immunology, and allergies. This funding opportunity (NOFO PAR-23-198) allows for applications proposing innovative, interdisciplinary research concepts. Eligible candidates include postdoctoral researchers or newly independent investigators with Early Stage Investigator status, who may request up to $300,000 annually for a maximum of five years. Submission of applications through the Grants.gov platform is mandated, alongside compliance with the updated NIH policies, including data sharing and resource management. Applications must describe the significance and innovation of proposed research, emphasizing creativity and the potential for major scientific advancements. Peer review evaluates the application’s significance, approach, investigator qualifications, and overall impact to determine funding merit. Key deadlines include the opening date on September 13, 2023, with applications due by 5 PM local time. The goal of this award is to foster groundbreaking research that may not yet have sufficient preliminary data, promoting independence and innovation among emerging researchers in the biomedical field.
    Similar Opportunities
    NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Director's New Innovator Award Program (DP2 Clinical Trial Optional), aimed at supporting early-stage investigators with innovative research projects that have the potential for significant impact in the biomedical sciences. This grant program encourages applications from a diverse range of eligible applicants, including Indian/Native American Tribal Governments, faith-based organizations, and foreign institutions, with no cost-sharing or matching requirements. The total estimated funding for this program is $23 million, with an award ceiling and floor set at $475,000, and approximately 30 awards expected to be made. Interested applicants can reach out to the NIH Director's New Innovator Award Program via email at NewInnovatorAwards@mail.nih.gov, with applications due by August 19, 2026, and project start dates anticipated for September 30, 2026.
    NEI New Innovator Award (DP2 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI New Innovator Award, a federal grant aimed at supporting early-stage investigators and postdoctoral candidates in vision research. This opportunity encourages innovative and original research proposals that have the potential to significantly impact the field of vision science, particularly those that explore novel methodologies or interdisciplinary approaches. The program anticipates awarding four grants, with no cost-sharing requirements, and applications are due by May 25, 2026, with an estimated award date of August 2, 2026. For further inquiries, interested applicants can contact Ed Clayton, Ph.D., at 240-987-8255 or via email at Ed.clayton@nih.gov.
    NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Career Transition Award (K22), a federal grant designed to support postdoctoral fellows in their transition to independent research scientist roles at academic institutions. This grant aims to assist candidates in developing independent research programs and applying for regular research grants, with a focus on enhancing the scientific workforce in biomedical research, particularly in infectious diseases. Eligible applicants include higher education institutions, nonprofits, and government agencies, with funding of up to $150,000 available for the first year and up to $100,000 for the second year, requiring a full-time commitment of at least 75% effort to research activities. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with applications due by January 7, 2028.
    NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Director's Early Independence Awards (DP5 Clinical Trial Optional), aimed at supporting promising investigators who wish to embark on independent research immediately following their terminal doctoral degree or post-graduate clinical training. This grant allows recipients to bypass traditional post-doctoral training, thereby accelerating their entry into independent research careers across various areas within the biomedical sciences. With an estimated total program funding of $5.7 million, the NIH anticipates awarding approximately 10 grants, each with a funding amount of $350,000. Interested applicants can reach out to the NIH Director's Early Independence Award Program via email at EarlyIndependence@od.nih.gov, with applications due by September 4, 2026, and awards expected to be announced by September 15, 2026.
    NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIH Director's Early Independence Awards (DP5 Clinical Trial Optional), aimed at supporting promising investigators who wish to pursue independent research shortly after completing their terminal doctoral degree or post-graduate clinical training. Eligible applicants must be in a non-independent research position at the time of application and are limited to submitting two applications per institution, with significant institutional commitment required. This funding opportunity, which has an estimated total program funding of $5,100,000 and expects to award approximately nine grants, is part of the High-Risk, High-Reward Research program and encourages applications across all topics relevant to NIH's mission. Interested applicants can reach out to Becky Miller, Ph.D., at earlyindependence@od.nih.gov or by phone at 301-594-9979, with the application process expected to open on September 10, 2025, and close on October 10, 2025.
    NIAID Investigator Initiated Program Project Applications
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is inviting applications for the Investigator Initiated Program Project Grants aimed at advancing research in areas pertinent to the NIAID mission. This program encourages small businesses to propose innovative projects that explore the biology and pathogenesis of microbes, immune system functions, and the development of vaccines and therapeutics for infectious and immune-mediated diseases. The grant does not require cost-sharing or matching, with an estimated award date set for December 1, 2026, and applications are due by January 25, 2026. For further inquiries, interested applicants can contact Dr. Chelsea Boyd at chelsea.boyd@nih.gov or by phone at 301-761-6664.
    Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)." This initiative aims to support new investigators from diverse and underrepresented backgrounds in biomedical research, enabling them to conduct small-scale projects that align with the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other participating institutes. The grants, with a maximum budget of $125,000 per year for a project period not exceeding three years, are intended to facilitate the transition of these researchers toward independence while addressing health disparities. Interested applicants must demonstrate that they have had less than $125,000 in direct costs from combined active research funding and can submit proposals starting in early 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-097.html.
    NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Director's Pioneer Award Program (DP1 Clinical Trial Optional), aimed at supporting individual scientists with exceptional creativity who propose innovative research projects in the biomedical sciences. Applicants are encouraged to present pioneering research that diverges significantly from existing scientific directions, with the potential for substantial impact on areas relevant to NIH's mission. The program has an estimated total funding of $8.1 million, with each award set at $700,000, and anticipates making approximately eight awards. Interested applicants can reach out to the NIH Director's Pioneer Award Program via email at PioneerAwards@mail.nih.gov, with applications due by September 9, 2026, and project start dates expected by September 30, 2026.
    Funding Opportunity for NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIH Director’s Pioneer Award Program, aimed at supporting innovative research projects with significant potential impact in health-related fields. This grant is designed for individual scientists of exceptional creativity who propose bold and high-risk research initiatives, emphasizing the investigator's qualities and the innovativeness of their proposals. The program anticipates awarding approximately $8.1 million across seven grants, with applications expected to open in June 2025 and close in September 2025. Interested applicants can reach out to Dr. Patricia Labosky at PioneerAwards@mail.nih.gov or by phone at 301-594-4863 for further information.
    Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed), aimed at supporting innovative research projects that signify a new direction for early stage investigators (ESIs). Applicants must propose projects without any preliminary data and align their research with the mission of participating NIH Institutes and Centers, while clinical trials are explicitly prohibited. This grant initiative is crucial for fostering innovation among ESIs, allowing them to explore novel research avenues over a maximum project period of five years. Interested applicants should note that the first application deadline is August 25, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.